Who owns iShares Dow Jones US Pharm Indx?

Key details on iShares Dow Jones US Pharm Indx (Ticker: IHE)

Who owns iShares Dow Jones US Pharm Indx?

Is IHE a good stock to own? Find out who bought iShares Dow Jones US Pharm Indx, who sold iShares Dow Jones US Pharm Indx (IHE) stock, and who holds a large position in iShares Dow Jones US Pharm Indx.

Fund Name Number of Shares Share Valuation As Of
Mandatum Life Insurance 678940 $692518 Dec. 31, 2015
BANK OF MONTREAL /CAN/ 317905 $54.81M March 31, 2015
MORGAN STANLEY 300124 $48.53M Dec. 31, 2015
GOLDMAN SACHS 250141 $40.45M Dec. 31, 2015
Bank of America Corporation 237631 $38.45M Dec. 31, 2015
Niemann Capital Management 184992 $16.58M Sept. 30, 2012
LPL Financial 139325 $22.12M Dec. 31, 2015
Wells Fargo & Company 132730 $21.12M Dec. 31, 2015
Royal Bank of Canada 115914 $18.74M Dec. 31, 2015
Brookstone Capital Management 110398 $16.34M Sept. 30, 2015
Braver Wealth Management 100904 $14.94M Sept. 30, 2015
FMR 98689 $9.83M June 30, 2013
Brown Advisory Holdings Incorporated 88889 $14.37M Dec. 31, 2015
SPC Financial 79315 $10.87M March 31, 2016
Raymond James & Associates 77957 $13.63M June 30, 2015
UBS Group AG 70862 $11.46M Dec. 31, 2015
SPINNAKER TRUST 69742 $9.55M March 31, 2016
Clark Capital Management 62550 $7.92M March 31, 2014
UBS AG 58779 $7.94M June 30, 2014
Rafferty Asset Management 57900 $5.77M June 30, 2013
CLS Investments 57000 $7.22M March 31, 2014
BANK HAPOALIM BM 56270 $1.61M March 31, 2015
Knight Capital 51820 $4.41M Dec. 31, 2012
Raymond James Financial Services Advisors 51353 $8.85M March 31, 2015

Who sold iShares Dow Jones US Pharm Indx?

Fund Name Date Sold Number of Shares Sold Share Valuation
RiverFront Investment March 31, 2010 73673 $4.40M